<DOC>
	<DOCNO>NCT00278551</DOCNO>
	<brief_summary>Rheumatoid arthritis ( RA ) chronic illness , immunologically mediate , probably induced exposure antigen antigen , immunologic tolerance lose . The disease variable course , mild , intermittently symptomatic illness require symptomatic therapy fulminant illness require dangerous immunosuppressive therapy , surgery . The molecular defect cause RA characterize , may involve aberrant T cell , B cell , macrophage function . Although RA often respond immunosuppressive medication include corticosteroid , methotrexate , azathioprine cyclophosphamide , non-steroidal anti-inflammatory drug , therapy curative . In patient severe RA , unresponsive corticosteroid , 20 active joint vasculitis , propose , phase I-II study , complete immune ablation subsequent reconstitution autologous vitro T lymphocyte deplete PBSCs harvest patient prior immune ablation . The combination high dose cyclophosphamide anti-thymocyte globulin conditioning follow rescue autologous lymphocyte deplete PBSCs . Subsequent disease activity follow : ( 1 ) RA disease activity index , ( 2 ) type amount therapy RA , ( 3 ) flow cytometry peripheral blood lymphocyte subset , ( 4 ) joint count , ( 5 ) patient ' assessment pain , ( 6 ) arthritis impact measurement scale ( AIMS ) questionnaire , ( 7 ) acute phase reactant . This study dose standard therapy , i.e . immune suppression , point complete immune ablation subsequent recapitulation lymphocyte ontogeny PBSC rescue . We anticipate study also form basis clarify role immune system RA .</brief_summary>
	<brief_title>Stem Cell Support Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>1 . Physiologic age &lt; 60 year old &gt; 18 year old . 2 . An established clinical diagnosis rheumatoid arthritis American College Rheumatology criterion , positive rheumatoid factor require . 3 . Patients must fail two diseasemodifying agent , methotrexate , plaquenil , gold , azathioprine , asulfidine Dpenicillamine . 4 . Patients must six ( 6 ) swollen joint active RA either thirty ( 30 ) great involve joint ( swell , tenderness , deformity , pain motion , decrease motion ) , answer less 75 percent Health Assessment Questionnaire ( HAQ ) question `` without difficulty . '' 5 . A harvest PBSC great 1.4 x 106 CD34+ cell /kg CD34+ selection necessary patient proceed transplant . 6 . Ability give inform consent 7 . Patients Juvenile Rheumatoid Arthritis ( JRA ) candidate disease onset polyarthritic systemic least 6 swollen joint fail corticosteroid two diseasemodifying drug 1 . HIV positive 2 . History coronary artery disease , congestive heart failure . 3 . Uncontrolled diabetes mellitus , illness opinion investigator would jeopardize ability patient tolerate aggressive chemoradiotherapy 4 . Prior history malignancy except localize basal cell squamous skin cancer . Other malignancy patient judge cured local surgical therapy , head neck cancer , stage I breast cancer consider individual basis . 5 . Positive pregnancy test , inability unwillingness pursue effective mean birth control , failure willingly accept comprehend irreversible sterility side effect therapy . 6 . Psychiatric illness mental deficiency make compliance treatment inform consent impossible 7 . FEV1/FVC &lt; 75 % predict , DLCO &lt; 50 % predict . 8 . Resting LVEF &lt; 45 % 9 . Bilirubin &gt; 2.0 mg/dl , transferase ( AST ) &gt; 2x upper limit normal 10 . Serum creatinine &gt; 2.0 mg/dl 11 . Platelet count less 100,000/ul , ANC less 1000/ul 12 . History allergy egg murine proteins 13 . Known hypersensitivity E. coli derive protein</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>